Replies to post #89986 on Biotech Values

[ThatStockGuy]

Achillion Pharmaceuticals Raised To Outperform From Neutral By Wedbush Morgan >ACHNLast update: 2/2/2010 8:45:10 AM(END) Dow Jones NewswiresFebruary 02, 2010 08:45 ET (13:45 GMT)

[dewophile]

re new achn PI

Anything longer than what is needed for qD dosing is immaterial from a commercial standpoint

you can even make an argument that a very long half life is a negative since it would take longer for toxicities to resolve upon discontinuation should AEs emerge. i'm also not quite sure what the implications would be for conformulation since it would take much longer to reach steady state than other compounds in a combination pill